Alembic Pharmaceuticalshas received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...

President Donald Trump has just announced that the highly popular weight loss drugs Wegovy and Zepbound-produced by Novo ...

Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire / November 4, 2025 / Ignite Biomedical, Inc.

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

Today in health care, aside from the overarching debate about keeping people insured, nothing likely dominates the debates, especially the political ones, more than the cost of prescription drugs.

Oz acknowledged obesity isn't "a deficiency of GLP drugs" but called reducing costs "a belt-and-suspenders approach." ...

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that ...

Numerous recalls have been issued this year due to the potential for damaged products and undeclared food allergens.

The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

The Trump administration announced deals with Novo Nordisk and Lilly to sell their weight loss products at a discounted rate ...

A key player driving the digital revolution within this complex ecosystem is L7 Informatics, Inc., an Austin, Texas-based ...